| 1 |
exp Retinal Diseases/ use mesz |
91346 |
| 2 |
exp retina disease/ use emez |
164020 |
| 3 |
exp Choroidal Neovascularization/ use mesz |
3590 |
| 4 |
exp subretinal neovascularization/ use emez |
6130 |
| |
((macul* adj2 (degenerat* or edema*)) or (age-relat* adj2 maculopath*) or choroidal |
|
| 5 |
neovascularis* or retinopath* or uveitic maculopath* or central serous retinopath* or epiretinal membrane*).ti,ab. |
92977 |
| 6 |
(diabet* adj4 (macul* or retin*)).ti,ab. |
37763 |
| 7 |
exp Macular Edema/ use mesz |
3669 |
| 8 |
exp Diabetes Mellitus/ use mesz |
287906 |
| 9 |
and/7–8 |
1516 |
| 10 |
or/1–6,9 |
276766 |
| 11 |
exp Tomography, Optical Coherence/ use mesz |
10441 |
| 12 |
exp optical coherence tomography/ use emez |
16148 |
| 13 |
(optical coherence adj5 tomograph*).ti,ab. |
22967 |
| 14 |
((spectral or fourier) adj2 domain*).ti,ab. |
6037 |
| 15 |
(CIRRUS or SPECTRALIS or FD?OCT or 3D OCT?1000 or RTVue or SOCT or OCT?SLO or oct).mp. |
35011 |
| 16 |
or/11–15 |
51117 |
| 17 |
10 and 16 |
14101 |
| 18 |
Meta Analysis.pt. |
36965 |
| 19 |
Meta Analysis/ use emez |
68704 |
| 20 |
Systematic Review/ use emez |
57019 |
| 21 |
exp Technology Assessment, Biomedical/ use mesz |
8791 |
| 22 |
Biomedical Technology Assessment/ use emez |
11436 |
| |
(meta analy* or metaanaly* or pooled analysis or (systematic* adj2 review*) or published |
|
| 23 |
studies or published literature or medline or embase or data synthesis or data extraction or cochrane).ti,ab. |
301636 |
| 24 |
((health technolog* or biomedical technolog*) adj2 assess*).ti,ab. |
3949 |
| 25 |
exp Random Allocation/ use mesz |
76124 |
| 26 |
exp Double-Blind Method/ use mesz |
117322 |
| 27 |
exp Control Groups/ use mesz |
1362 |
| 28 |
exp Placebos/ use mesz |
31199 |
| 29 |
Randomized Controlled Trial/ use emez |
336510 |
| 30 |
exp Randomization/ use emez |
60645 |
| 31 |
exp Random Sample/ use emez |
4554 |
| 32 |
Double Blind Procedure/ use emez |
112949 |
| 33 |
exp Triple Blind Procedure/ use emez |
37 |
| 34 |
exp Control Group/ use emez |
41699 |
| 35 |
exp Placebo/ use emez |
212212 |
| 36 |
(random* or RCT).ti,ab. |
1410151 |
| 37 |
(placebo* or sham*).ti,ab. |
454141 |
| 38 |
(control* adj2 clinical trial*).ti,ab. |
39002 |
| 39 |
exp Practice Guideline/ use emez |
285300 |
| 40 |
exp Professional Standard/ use emez |
275062 |
| 41 |
exp Standard of Care/ use mesz |
620 |
| 42 |
exp Guideline/ use mesz |
23122 |
| 43 |
exp Guidelines as Topic/ use mesz |
102366 |
| 44 |
(guideline* or guidance or consensus statement* or standard or standards).ti. |
222163 |
| 45 |
(controlled clinical trial or meta analysis or randomized controlled trial).pt. |
455842 |
| 46 |
or/18–45 |
3028958 |
| 47 |
17 and 46 |
1178 |
| 48 |
limit 47 to english language |
1060 |
| 49 |
limit 48 to yr=“2008 -Current” |
788 |
| 50 |
remove duplicates from 49 |
535 |